Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ibio Inc (IBIO)

Ibio Inc (IBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ibio Inc 600 Madison Avenue Suite 1601 New York NY 10022 USA

P: 302-355-0650 F: 302-356-1173

Description:

Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture of proteins applicable to a range of disease agents, such as influenza, sleeping sickness, anthrax, plague, human papillomavirus and veterinary influenza applications. IBio, Inc. is headquartered in Newark, Delaware.

Key Statistics

Overview:

Market Capitalization, $K 262,759
Shares Outstanding, K 118,360
Annual Sales, $ 2,020 K
Annual Net Income, $ -17,590 K
Last Quarter Sales, $ 100 K
Last Quarter Net Income, $ -4,680 K
60-Month Beta -5.98
% of Insider Shareholders 0.30%
% of Institutional Shareholders 2.69%
Float, K 118,005
% Float 99.70%

Growth:

1-Year Return 221.65%
3-Year Return -38.33%
5-Year Return -73.88%
5-Year Revenue Growth 861.90%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/21/20
Earnings Per Share ttm -1.02
EPS Growth vs. Prev Qtr 91.30%
EPS Growth vs. Prev Year 72.73%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-10 on 06/11/18

IBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -7.00
Price/Earnings to Growth N/A
Return-on-Equity % -1,760.75%
Return-on-Assets % -48.23%
Profit Margin % -870.79
Net Margin % N/A
Debt/Equity 8.11
Price/Sales 68.04
Price/Cash Flow N/A
Price/Book 58.45
Book Value/Share 0.04
Interest Coverage -8.26
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar